Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K5IQ
|
||||
Former ID |
DIB006502
|
||||
Drug Name |
DAA-1097
|
||||
Synonyms |
DAA-1106
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Terminated | [547051] | ||
Company |
Taisho Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H24ClNO3
|
||||
Canonical SMILES |
N(c1c(cc(cc1)Cl)Oc1ccccc1)(Cc1c(OC(C)C)cccc1)C(=O)C
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [525488] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
HTLV-I infection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.